Ha Tay Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	84,337	90,270	301,790	93,132	59,669
Short-Term Investments	150,000	90,000	80,000	53,000	362,814
Cash & Short-Term Investments	234,337	180,270	381,790	146,132	422,483
Cash Growth	29.99%	-52.78%	161.26%	-65.41%	446.74%
Accounts Receivable	109,964	125,685	89,463	109,915	121,112
Other Receivables	1,070	7,927	8,412	8,964	6,859
Receivables	111,035	133,612	97,875	118,879	127,972
Inventory	509,472	527,935	378,908	460,629	339,706
Other Current Assets	37,971	83,045	150,099	285,297	117,125
Total Current Assets	892,815	924,861	1,008,673	1,010,937	1,007,287
Property, Plant & Equipment	1,000,716	976,101	791,736	442,074	212,752
Long-Term Investments	19,860	19,336	33,969	11,144	9,486
Other Intangible Assets	1,377	1,377	1,377	1,593	1,810
Long-Term Deferred Tax Assets	1,186	-	-	-	-
Other Long-Term Assets	12,039	4,631	2,510	3,754	6,256
Total Assets	1,927,992	1,926,305	1,838,264	1,469,502	1,237,591
Accounts Payable	257,336	235,207	146,324	196,455	114,143
Accrued Expenses	33,500	20,668	12,204	16,251	15,269
Short-Term Debt	236,151	373,274	333,483	234,630	289,429
Current Portion of Long-Term Debt	13,845	-	-	-	-
Current Income Taxes Payable	4,550	6,057	4,958	8,758	6,288
Current Unearned Revenue	6,418	909.3	1,008	785.26	551.02
Other Current Liabilities	178,298	131,637	98,012	106,263	53,399
Total Current Liabilities	730,098	767,752	595,988	563,143	479,079
Long-Term Debt	83,068	96,913	170,218	102,213	-
Other Long-Term Liabilities	3,626	4,880	4,908	5,306	5,167
Total Liabilities	816,792	869,545	771,114	670,662	484,245
Common Stock	905,756	823,418	823,418	264,088	264,088
Additional Paid-In Capital	37,282	97,320	97,320	315,934	315,934
Retained Earnings	121,105	90,280	99,006	81,831	79,048
Treasury Stock	-8,084	-8,084	-8,084	-8,084	-8,084
Comprehensive Income & Other	26,612	26,612	26,612	119,572	78,779
Total Common Equity	1,082,671	1,029,546	1,038,273	773,341	729,766
Minority Interest	28,529	27,214	28,877	25,499	23,580
Shareholders' Equity	1,111,201	1,056,760	1,067,150	798,841	753,345
Total Liabilities & Equity	1,927,992	1,926,305	1,838,264	1,469,502	1,237,591
Total Debt	333,064	470,187	503,700	336,844	289,429
Net Cash (Debt)	-98,727	-289,917	-121,910	-190,711	133,054
Net Cash Per Share	-1090.01	-3200.88	-2191.63	-	1648.53
Filing Date Shares Outstanding	90.57	90.57	55.63	-	81.33
Total Common Shares Outstanding	90.57	90.57	55.63	-	81.33
Working Capital	162,717	157,109	412,684	447,795	528,208
Book Value Per Share	11953.44	11366.87	18665.49	-	8972.40
Tangible Book Value	1,081,295	1,028,170	1,036,896	771,748	727,956
Tangible Book Value Per Share	11938.24	11351.67	18640.75	-	8950.14
Buildings	168,480	165,434	150,724	-	148,602
Machinery	277,573	272,572	234,134	-	200,702
Construction In Progress	827,184	790,110	638,852	301,451	64,931

Source: S&P Global Market Intelligence. Standard template. Financial Sources.